background
polymeras
base
amplif
method
provid
amplifi
dna
minim
chang
sequenc
rel
abund
mani
biomed
applic
rna
viru
detect
use
microarray
howev
present
challeng
dna
polymeras
amplifi
rna
small
cdna
fragment
base
obtain
revers
transcript
certain
viral
rna
genom
therefor
ligat
cdna
fragment
necessari
prior
polymeras
base
amplif
adapt
quantitect
whole
transcriptom
kit
qiagen
purpos
design
method
whole
transcriptom
amplif
wta
result
wta
success
amplifi
cdna
panel
rna
virus
repres
divers
riboviru
genom
size
amplifi
rang
genom
copi
number
use
wta
yield
quantiti
amplifi
dna
high
target
copi
amplif
factor
vari
also
demonstr
coamplif
occur
viral
rna
mix
bacteri
dna
conclus
first
report
scientif
literatur
show
modifi
wga
wta
approach
success
appli
viral
genom
rna
size
amplifi
viral
rna
wta
provid
consider
better
sensit
accuraci
detect
compar
random
rtpcr
parallel
nucleic
acid
sequenc
detect
requir
suffici
quantiti
microgram
rang
dna
subsequ
hybridizationbas
method
use
dna
microarray
resequenc
array
rna
viru
detect
target
dna
repres
amplifi
product
revers
transcript
rt
rt
dna
amplif
achiev
either
use
primer
specif
relev
virus
random
prime
although
random
prime
amplifi
unknown
target
often
yield
lower
amount
dna
specif
primer
reduc
overal
sensit
process
multipl
displac
amplif
mda
use
bacteriophag
polymeras
random
primer
allow
dna
synthesi
amount
compat
downstream
use
dna
microarray
moreov
mda
potenti
amplifi
whole
dna
genom
whole
genom
amplif
wga
target
pathogen
presenc
contamin
dna
wga
technolog
becom
use
upfront
amplif
method
mani
biomed
applic
microsatellit
analysi
singl
nucleotid
polymorph
snp
detect
compar
genom
hybrid
cgh
microarray
recent
show
wga
use
dna
viral
pathogen
detect
clinic
sampl
use
resequenc
microarray
inde
resequenc
technolog
use
microarray
promis
bacteri
viral
pathogen
detect
identif
well
determin
pathogen
profil
howev
mda
use
amplifi
rna
small
cdna
obtain
rna
genom
revers
transcript
small
nativ
dna
fragment
gener
rt
segment
ribovir
genom
therefor
mda
previous
use
ribovirus
novel
modifi
mda
approach
qiagen
design
quantitect
whole
transcriptom
develop
transcriptom
studi
chang
process
use
differ
revers
transcript
strategi
contain
random
primer
instead
mixtur
random
oligodt
primer
differ
revers
transcriptas
wta
process
revers
transcript
rna
util
random
primer
cdna
ligat
togeth
longer
linear
chain
allow
concaten
cdna
small
rna
fragment
use
templat
mda
appli
wta
viral
rna
demonstr
wta
applic
cdna
amplif
whole
rang
rna
viru
genom
prior
dna
hybrid
base
techniqu
half
dozen
approach
develop
random
whole
genom
amplif
upstream
snp
detect
method
eg
omniplex
technolog
doppcr
lapcr
pcr
univers
linker
base
linear
amplif
genom
dna
among
wga
random
amplif
ra
base
random
rt
random
pcr
widespread
techniqu
detect
identif
use
dna
microarray
studi
chose
compar
wta
ra
final
dna
yield
gener
ra
wta
absenc
presenc
prokaryot
dna
evalu
quantit
pcr
qpcr
accuraci
identif
highdens
microarray
also
compar
ra
wta
process
total
rna
brain
biopsi
mg
obtain
use
ml
tri
reagent
molecular
research
center
accord
manufactur
instruct
rna
extract
perform
use
qiaamp
viral
rna
mini
kit
qiagen
accord
manufactur
instruct
complementari
strand
cdna
extract
viral
rna
perform
tube
primer
use
ra
describ
wang
et
al
wherea
cdna
synthesi
wta
perform
random
hexam
primer
concentr
except
influenza
b
viru
experi
final
concentr
dilut
mix
rna
primer
dntp
mm
incub
min
cool
ice
min
enzym
mix
ad
enzym
mix
compos
rt
buffer
ssiii
invitrogen
inc
mm
mgcl
dtt
rnaseout
invitrogen
inc
revers
transcriptas
superscript
iii
invitrogen
inc
dmso
sigmaaldrich
final
mix
submit
follow
step
min
min
min
cdna
store
immedi
use
synthesi
complementari
strand
secondstrand
dna
synthesi
carri
addit
klenow
mix
consist
klenow
buffer
dntp
mm
klenow
dna
polymeras
biolab
final
mix
incub
min
min
subsequ
result
doubl
strand
dna
use
templat
cycl
pcr
primer
e
previous
describ
wang
et
al
except
addit
dmso
use
takara
dna
polymeras
instead
taq
dna
polymeras
viral
rna
amplif
perform
describ
protocol
quantitect
whole
transcriptom
kit
qiagen
except
cdna
synthesi
step
replac
revers
transcript
protocol
describ
two
follow
step
perform
accord
manufactur
instruct
qiagen
amplif
viral
rna
bacteri
dna
mention
base
wta
amplif
process
describ
except
ligat
step
nucleic
acid
denatur
perform
ad
denatur
solut
avail
replig
midi
kit
qiagen
incub
min
room
temperatur
final
amplif
step
perform
accord
manufactur
instruct
qiagen
identifi
rift
valley
fever
viru
rvfv
rtqpcr
perform
primer
publish
drosten
et
al
use
lc
rna
amplif
kit
sybrgreen
roch
diagnost
differ
rt
pcr
cycl
condit
detect
quantif
involv
follow
step
revers
transcript
min
initi
denatur
cycl
fluoresc
read
combin
annealingextens
step
lightcycl
instrument
roch
diagnost
use
amplifi
bp
region
aureu
nuca
gene
lc
faststart
dna
master
plu
sybrgreen
kit
pcr
perform
total
volum
contain
master
mixtur
includ
taq
polymeras
reaction
buffer
deoxynucleosid
triphosph
mixtur
pure
water
forward
gactattattggttgatacacctg
revers
gccttgacgaactaaagcttc
primer
distribut
master
mixtur
dilut
templat
dna
solut
ad
glass
capillari
roch
diagnost
centrifug
place
lightcycl
sampl
carousel
lightcycl
amplif
involv
first
denatur
min
follow
amplif
target
dna
cycl
temperatur
transit
rate
fragment
amplif
step
follow
melt
curv
analysi
increas
rate
purif
dna
obtain
quantifi
use
qubit
quantit
platform
either
quantit
dsdna
hs
assayquantit
dsdna
br
assay
kit
dna
quantit
rna
assay
kit
rna
recommend
manufactur
invitrogen
dna
amount
obtain
amplif
quantifi
quantit
br
quantit
hs
invitrogen
inc
wta
ra
respect
quantiti
dna
fragment
genechip
resequenc
assay
kit
affymetrix
inc
label
accord
genechip
map
k
assay
manual
affymetrix
inc
microarray
hybrid
conduct
array
process
carri
accord
protocol
recommend
manufactur
affymetrix
inc
previous
describ
experi
describ
studi
carri
use
independ
duplic
raw
imag
file
dat
obtain
scan
microarray
analyz
use
affymetrix
genechip
oper
softwar
gco
produc
simplifi
file
format
cel
intens
assign
correspond
probe
posit
next
affymetrix
genechip
sequenc
analysi
softwar
gseq
contain
deriv
abacu
algorithm
use
probe
intens
call
base
along
genet
fragment
includ
microarray
output
result
fasta
file
analysi
paramet
optim
order
obtain
best
call
rate
valu
minimis
rate
resequenc
error
call
rate
fragment
simpli
ratio
call
base
total
number
base
express
percentag
detail
concern
data
analysi
describ
berthet
et
al
polymeras
requir
dna
templat
larger
kb
exce
size
smallest
rna
strand
segment
rna
virus
eg
influenza
virus
address
shortcom
target
cdna
ligat
step
perform
prior
mda
amplif
result
wta
protocol
work
wta
compar
ra
protocol
describ
materi
method
dna
yield
obtain
use
wta
ra
method
compar
three
differ
viral
rna
genom
test
viral
genom
fragment
small
segment
influenza
b
viru
kb
segment
ii
fragment
middl
size
genom
rift
valley
fever
viru
rvfv
kb
segment
iii
larg
viral
genom
sever
acut
respiratori
syndrom
coronaviru
sarscov
kb
segment
repres
extrem
divers
rna
viral
genom
size
wta
dna
yield
respect
yield
greatli
exceed
observ
ra
respect
noteworthi
absenc
dna
templat
water
control
amplifi
wta
yield
much
nonspecif
dna
spuriou
amplif
probabl
due
prime
artefact
e
coli
residu
dna
product
process
one
kit
enzym
howev
presenc
dna
templat
aureu
dna
proport
nonspecif
dna
dramat
decreas
undetect
level
use
previous
describ
dna
microarray
techniqu
high
amplif
factor
obtain
start
wta
variou
viral
genom
equival
start
wta
copi
rvfv
rna
genom
copi
wta
amplif
factor
rang
wherea
ra
factor
vari
respect
figur
comparison
ra
amplif
viral
rna
extrem
high
irrespect
amount
rna
genom
input
sensit
detect
identif
protocol
base
resequenc
microarray
technolog
determin
measur
lowest
number
genom
copi
target
appli
microarray
figur
show
call
rate
rna
polymeras
gene
rvfv
express
function
number
genom
copi
call
rate
percentag
base
call
resequenc
algorithm
see
microarray
requir
minimum
viral
genom
copi
gene
detect
identif
confirm
blast
analysi
high
amplif
ratio
obtain
wta
allow
detect
rvfv
irrespect
copi
number
input
viral
rna
amplif
process
sensit
level
compat
viral
load
found
clinic
sampl
sharp
contrast
low
amplif
ratio
observ
ra
irrelev
clinic
situat
requir
high
viral
load
detect
microarray
ie
obtain
requir
copi
target
sequenc
hybrid
evalu
potenti
wta
complex
sampl
viral
rna
mix
cellular
rna
dna
human
n
mous
n
dog
n
rabiesinfect
brain
extract
test
hybrid
wta
amplifi
materi
dna
chip
describ
previous
sampl
found
posit
presenc
rabi
viru
minimum
call
rate
comparison
amplif
factor
whole
transcriptom
amplif
wta
random
amplif
ra
protocol
figur
comparison
amplif
factor
whole
transcriptom
amplif
wta
random
amplif
ra
protocol
number
rvfv
copi
amplif
express
function
amount
input
dna
number
genom
copi
amount
rvfv
rna
amplif
estim
qpcr
rvfv
describ
order
assess
qualiti
amplifi
cdna
hybrid
high
densiti
dna
resequenc
array
perform
call
rate
valu
sequenc
determin
analysi
compar
aim
viral
amplif
use
wta
perform
seven
virus
repres
size
divers
viral
genom
rna
includ
posit
neg
strand
genom
well
nonseg
segment
genom
tabl
data
confirm
wta
method
amplifi
viral
cdna
cell
cultur
supernat
identifi
viru
hybrid
case
viru
identif
accomplish
use
blast
analysi
dna
sequenc
determin
use
resequenc
chip
previou
studi
detect
identifi
dna
monkeypox
viru
staphylococcu
aureu
skin
lesion
collect
patient
similarli
want
check
whether
coinfect
rna
viru
aureu
would
lead
discrimin
result
bear
mind
ratio
amount
genet
materi
rna
viru
bacteria
even
higher
therefor
evalu
influenc
rna
dna
divers
origin
amplif
result
simultan
amplif
viral
rna
bacteri
dna
perform
use
optim
wta
protocol
describ
shown
tabl
aureu
dna
amplif
affect
neither
amount
dna
presenc
viral
cdna
similarli
cdna
viral
rna
amplifi
whatev
quantiti
viral
genom
test
howev
amplif
ratio
decreas
presenc
larg
quantiti
aureu
dna
consid
sensit
threshold
identif
rvfv
figur
viru
would
identifi
hybrid
dna
chip
high
call
rate
ie
greater
case
shown
tabl
except
copi
viral
rna
copi
aureu
dna
similar
result
obtain
coamplif
rvfv
cdna
dna
cowpox
viru
data
shown
wta
allow
amplif
whole
rang
rna
viral
genom
high
sensit
therebi
provid
accur
highli
effect
altern
random
amplif
method
studi
chang
wta
method
quantitect
wholetranscriptom
kit
qiagen
use
differ
revers
transcript
step
demonstr
unbias
identif
mani
differ
virus
use
wta
oligonucleotid
resequenc
microarray
technolog
two
virus
belong
phylogenet
distinct
genera
vesiculoviru
lyssaviru
identifi
call
rate
respect
howev
amplif
output
may
vari
within
viral
genu
illustr
yellow
fever
dengu
virus
flaviviru
lower
call
rate
obtain
dengu
viru
might
due
secondari
structur
target
sequenc
suggest
higher
call
rate
obtain
yellow
fever
viru
whose
target
sequenc
lack
structur
result
demonstr
effect
select
sequenc
final
output
mention
analysi
human
mous
dog
brain
sampl
detect
rabi
viru
presenc
eukaryot
nucleic
acid
prevent
either
amplif
use
wta
downstream
identif
pathogen
dna
microarray
wta
amplifi
huge
divers
viral
rna
also
bacteri
rna
transcrib
ribosom
housekeep
antibiot
resist
gene
extract
either
pure
bacteri
cultur
clinic
sampl
data
shown
simultan
amplif
cdna
bacteri
viral
rna
would
use
character
mani
differ
type
pathogen
caus
similar
symptom
respiratori
syndrom
provid
consider
potenti
medic
use
sampl
contain
genom
copi
viral
rna
per
target
per
quantif
amplif
determin
qpcr
describ
sa
saureu
reaction
could
amplifi
wta
yield
compat
detect
method
use
diagnosi
wta
could
thu
use
upstream
mani
pathogen
identif
protocol
clinic
sampl
eg
dna
microarray
liquid
dna
array
southern
blot
modifi
qpcr
use
exonucleas
hybrid
probe
dna
polymer
catalyz
dna
polymeras
highli
accur
process
direct
sequenc
experi
sampl
bp
determin
error
rate
make
one
accur
polymeras
avail
wta
thu
provid
isotherm
altern
random
rtpcr
could
becom
invalu
method
diagnost
applic
particularli
use
conjunct
oligonucleotid
microarray
